 Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks Biotech Stocks Hitting 52-week highs on Feb. 4 Acceleron Pharma Inc NASDAQ: XLRN Alector Inc NASDAQ: ALEC Apellis Pharmaceuticals Inc NASDAQ: APLS Applied Therapeutics Inc NASDAQ: APLT Aptose Biosciences Inc NASDAQ: APTO Arcutis Biotherapeutics, Inc. NASDAQ: ARQT IPOed Jan. 31 Black Diamond Therapeutics Inc NASDAQ: BDTX IPOed Jan. 30 ChemoCentryx Inc NASDAQ: CCXI Eli Lilly And Co NYSE: LLY Fate Therapeutics Inc NASDAQ: FATE Frequency Therapeutics Inc NASDAQ: FREQ GALAPAGOS NVS ADR NASDAQ: GLPG Hologic, Inc. NASDAQ: HOLX Insmed Incorporated NASDAQ: INSM reacted to positive analyst actions following a positive data readout reported Monday Insulet Corporation NASDAQ: PODD Johnson Johnson NYSE: JNJ Masimo Corporation NASDAQ: MASI Medpace Holdings Inc NASDAQ: MEDP Molecular Templates Inc NASDAQ: MTEM Neoleukin Therapeutics Inc NASDAQ: NLTX PTC Therapeutics, Inc NASDAQ: PTCT Quest Diagnostics Inc NYSE: DGX Reata Pharmaceuticals Inc NASDAQ: RETA Repligen Corporation NASDAQ: RGEN ResMed Inc. 